5,754 followers
New Research: Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor #pharmacology https://t.co/1Sql6lWY9m
New Research: Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor #pharmacology https://t.co/1Sql6lWY9m